Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alison M Elliott

Showing results (211-220 of 312) with videos related to

Pageof 32
Sort By:
NIHR Open Research|August 15, 2024
NIHR Global Health Research Group on Vaccines for vulnerable people in Africa (VAnguard): Concept and Launch event reportLudoviko Zirimenya, Flavia Zalwango, Esther A Owino, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|September 12, 2017
Effects of treating helminths during pregnancy and early childhood on risk of allergy-related outcomes: Follow-up of a randomized controlled trialBenigna Namara, Stephen Nash, Swaib A Lule, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|September 15, 2004
Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective studyAlison M Elliott, Wendy S Hodsdon, Jacqueline Kyosiimire, et al.
Scientific Reports|August 14, 2021
The determinants of lipid profiles in early adolescence in a Ugandan birth cohortJan Pieter R Koopman, Swaib A Lule, Christopher Zziwa, et al.
The Journal of Infectious Diseases|August 6, 2004
A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosisAlison M Elliott, Henry Luzze, Maria A Quigley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 11, 2024
Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from CanadaDean A Regier, Rosalie Loewen, Brandon Chan, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 24, 2020
Risk factors associated with rhinitis, allergic conjunctivitis and eczema among schoolchildren in UgandaHarriet Mpairwe, Gyaviira Nkurunungi, Pius Tumwesige, et al.
Plos One|May 20, 2014
Prevalence of bloodstream pathogens is higher in neonatal encephalopathy cases vs. controls using a novel panel of real-time PCR assaysCally J Tann, Peter Nkurunziza, Margaret Nakakeeto, et al.
Trials|September 7, 2021
The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK/PD-driven randomised controlled trial of praziquantel in children under 4 years of ageEmily L Webb, Andrew Edielu, Hannah W Wu, et al.
Wellcome Open Research|September 4, 2018
High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study)Fiona V Cresswell, Kenneth Ssebambulidde, Daniel Grint, et al.
Pageof 32

Showing results (211-220 of 312) with videos related to

Sort By:
Pageof 32
NIHR Open Research|August 15, 2024
NIHR Global Health Research Group on Vaccines for vulnerable people in Africa (VAnguard): Concept and Launch event reportLudoviko Zirimenya, Flavia Zalwango, Esther A Owino, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|September 12, 2017
Effects of treating helminths during pregnancy and early childhood on risk of allergy-related outcomes: Follow-up of a randomized controlled trialBenigna Namara, Stephen Nash, Swaib A Lule, et al.
Transactions of the Royal Society of Tropical Medicine and Hygiene|September 15, 2004
Cytokine responses and progression to active tuberculosis in HIV-1-infected Ugandans: a prospective studyAlison M Elliott, Wendy S Hodsdon, Jacqueline Kyosiimire, et al.
Scientific Reports|August 14, 2021
The determinants of lipid profiles in early adolescence in a Ugandan birth cohortJan Pieter R Koopman, Swaib A Lule, Christopher Zziwa, et al.
The Journal of Infectious Diseases|August 6, 2004
A randomized, double-blind, placebo-controlled trial of the use of prednisolone as an adjunct to treatment in HIV-1-associated pleural tuberculosisAlison M Elliott, Henry Luzze, Maria A Quigley, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 11, 2024
Real-world diagnostic outcomes and cost-effectiveness of genome-wide sequencing for developmental and seizure disorders: Evidence from CanadaDean A Regier, Rosalie Loewen, Brandon Chan, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|October 24, 2020
Risk factors associated with rhinitis, allergic conjunctivitis and eczema among schoolchildren in UgandaHarriet Mpairwe, Gyaviira Nkurunungi, Pius Tumwesige, et al.
Plos One|May 20, 2014
Prevalence of bloodstream pathogens is higher in neonatal encephalopathy cases vs. controls using a novel panel of real-time PCR assaysCally J Tann, Peter Nkurunziza, Margaret Nakakeeto, et al.
Trials|September 7, 2021
The praziquantel in preschoolers (PIP) trial: study protocol for a phase II PK/PD-driven randomised controlled trial of praziquantel in children under 4 years of ageEmily L Webb, Andrew Edielu, Hannah W Wu, et al.
Wellcome Open Research|September 4, 2018
High dose oral and intravenous rifampicin for improved survival from adult tuberculous meningitis: a phase II open-label randomised controlled trial (the RifT study)Fiona V Cresswell, Kenneth Ssebambulidde, Daniel Grint, et al.
Pageof 32